Piramal Pharma Limited — Board Meeting, 14-05-2025: Outcome of Board Meeting

Piramal Pharma has announced a board meeting on May 28 to approve the financial results for the quarter and half-year. For FY25, consolidated revenue rose 12% YoY to Rs. 9,151 Cr, with profit after tax jumping to Rs. 91 Cr from Rs. 18 Cr last year, aided by no exceptional losses versus Rs. 63 Cr earlier. The Board proposed a final dividend of Rs. 0.14 per share. Leadership changes include Neeraj Bharadwaj’s resignation, Amit Jain from Carlyle joining as Additional Director, and Jairaj Purandare’s re-appointment for five years.